1X10^6 human PBMCs were surface co-stained with CL405 Anti-Human CD19 and 0.5 ug Anti-Human CD20 (65085-1-Ig, Clone: 2H7) and CoraLite®594-Conjugated AffiniPure Goat Anti-Mouse IgG(H+L) at dilution 1:1000 or Isotype Control. Cells were not fixed. Lymphocytes were gated.

---

1X10^6 human PBMCs were surface stained with 0.5 ug Anti-Human CD73 (65162-1-Ig, Clone:AD2) and CoraLite®594-Conjugated AffiniPure Goat Anti-Mouse IgG(H+L) at dilution 1:1000 (red) or Isotype Control. Cells were not fixed. Lymphocytes were gated.

---

1X10^6 human PBMCs were surface co-stained with FITC Anti-Human CD19 and 5 ul APC Anti-Human CD20 (APC-65085, Clone:2H7) or Mouse IgG2b Isotype Control. Cells were not fixed. Lymphocytes were gated.

---

1X10^6 human PBMCs were surface stained with 5 ul Atlantic Blue™ Anti-Human CD81 (AB-65195, Clone:5A6) or Mouse IgG1 Isotype Control (66360-1-Ig, Clone: T1F8D3F10). Cells were not fixed. Lymphocytes were gated.

---

1X10^6 human PBMCs were surface co-stained with FITC Anti-Human CD19 and 5 ul Atlantic Blue™ Anti-Human CD20 (AB-65085, Clone:2H7) or Mouse IgG2b Isotype Control. Cells were not fixed. Lymphocytes were gated.

---

1X10^6 human PBMCs were surface stained with 5 ul Atlantic Blue™ Anti-Human CD20 (AB-65085, Clone:2H7) or Mouse IgG2b Isotype Control. Cells were not fixed. Lymphocytes were gated.

---

1X10^6 human PBMCs were surface co-stained with APC Anti-Human CD19 and 5 ul Cardinal Red™ Anti-Human CD20 (CR-65085, Clone:2H7) or Mouse IgG2b Isotype Control. Cells were not fixed. Lymphocytes were gated.

---

1X10^6 human PBMCs were surface stained with 5 ul Cardinal Red™ Anti-Human CD20 (CR-65085, Clone:2H7) or Mouse IgG2b Isotype Control. Cells were not fixed. Lymphocytes were gated.

---

1X10^6 human PBMCs were surface co-stained with FITC Anti-Human CD19 and 5 ul CoraLite®405 Anti-Human CD20 (CL405-65085, Clone:2H7), or 5 ul Mouse IgG2b Isotype Control. Cells were not fixed. Lymphocytes were gated.

---

1X10^6 human PBMCs were surface stained with 5 ul CoraLite®405 Anti-Human CD20 (CL405-65085, Clone:2H7), or 5 ul Mouse IgG2b Isotype Control. Cells were not fixed. Lymphocytes were gated.

---

1X10^6 human peripheral blood lymphocytes were surface stained with 5.00 ul/test CoraLite®488-conjugated Anti-Human CD20 (CL488-65085, Clone: 2H7) (red) or isotype control antibody (blue). Cells were not fixed.

---

1X10^6 human PBMCs were surface co-stained with APC Anti-Human CD19 and 5 ul CoraLite® Plus 555 Anti-Human CD20 (CL555-65085, Clone:2H7) or Mouse IgG2b Isotype Control (66360-3-Ig, Clone: K11B8C4B5). Cells were not fixed. Lymphocytes were gated.

---

1X10^6 human PBMCs were surface stained with 5 ul CoraLite® Plus 555 Anti-Human CD20 (CL555-65085, Clone:2H7) or Mouse IgG2b Isotype Control (66360-3-Ig, Clone: K11B8C4B5). Cells were not fixed. Lymphocytes were gated.

---

1X10^6 human PBMCs were surface stained with CL750 CD19 and 5 ul CoraLite® Plus 594 Anti-Human CD20 (CL594-65085, Clone:2H7) or CoraLite®594 Mouse IgG2b Isotype Control. Cells were not fixed. Lymphocytes were gated.

---

1X10^6 human PBMCs were surface stained with 5 ul CoraLite® Plus 594 Anti-Human CD20 (CL594-65085, Clone:2H7) or CoraLite®594 Mouse IgG2b Isotype Control. Cells were not fixed. Lymphocytes were gated.

---